Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1095559-57-1

Post Buying Request

1095559-57-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1095559-57-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1095559-57-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,5,5,5 and 9 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1095559-57:
(9*1)+(8*0)+(7*9)+(6*5)+(5*5)+(4*5)+(3*9)+(2*5)+(1*7)=191
191 % 10 = 1
So 1095559-57-1 is a valid CAS Registry Number.

1095559-57-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-chloro-2-cyclobutylquinazoline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1095559-57-1 SDS

1095559-57-1Relevant articles and documents

SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1

-

Paragraph 00787, (2014/07/08)

Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Synthesis, resolution, and application of cyclobutyl- and adamantyl-quinazolinap ligands

Fekner, Tomasz,Mueller-Bunz, Helge,Guiry, Patrick J.

experimental part, p. 5055 - 5066 (2009/05/26)

An expedient, seven-step synthesis of two new members of the Quinazolinap ligand family, 2-cyclobutyl- and 2-(1-adamantyl)-Quinazolinaps, has been developed. The racemic ligands have been efficiently resolved by fractional crystallization of their diastereomeric palladacycle complexes. The enantioenriched ligands provide good levels of enantioselection (ee's up to 89%) in a prototypical PdII-catalyzed allylic alkylation reaction. 2-Cyclobutyl-Quinazolinap has been further functionalized at the 2-position via metalation with a superbase followed by reaction with a range of electrophiles. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1095559-57-1